Related Articles
Stanniocalcin 1 is a prognostic biomarker in glioma
RELB: A novel prognostic marker for glioblastoma as identified by population‑based analysis
RelB, a good prognosis predictor, links cell-cycle and migration to glioma tumorigenesis
Stromal protein periostin identified as a progression associated and prognostic biomarker in glioma via inducing an invasive and proliferative phenotype
CDH2 expression is of prognostic significance in glioma and predicts the efficacy of temozolomide therapy in patients with glioblastοma